CA Stock MarketDetailed Quotes

APS Aptose Biosciences Inc

Watchlist
  • 0.550
  • +0.020+3.77%
15min DelayMarket Closed Nov 4 15:13 ET
9.96MMarket Cap-94P/E (TTM)

Aptose Biosciences Inc Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
57.21%-5.78M
-4.08%-11.76M
-37.96%-44.59M
-7.03%-9.26M
-50.97%-10.54M
-91.61%-13.5M
-17.18%-11.3M
25.36%-32.32M
46.08%-8.65M
13.40%-6.98M
Net income from continuing operations
48.67%-7.25M
29.51%-9.64M
-22.44%-51.21M
-19.55%-11.96M
-17.08%-11.45M
-33.73%-14.13M
-19.12%-13.68M
36.01%-41.82M
58.89%-10M
13.73%-9.78M
Operating gains losses
--66K
--10K
----
----
----
----
----
385.71%20K
366.67%16K
----
Depreciation and amortization
-10.53%102K
-16.79%109K
-11.74%466K
10.00%110K
-21.28%111K
-19.15%114K
-10.27%131K
-15.11%528K
-38.65%100K
-9.03%141K
Unrealized gains and losses of investment securities
-50.00%1K
75.00%-1K
----
----
-114.29%-1K
--2K
---4K
----
----
--7K
Remuneration paid in stock
-73.08%207K
-56.83%809K
-29.84%3.65M
-52.26%411K
-43.11%599K
-1.28%769K
-25.46%1.87M
-59.79%5.21M
-62.79%861K
-42.40%1.05M
Other non cashItems
-84.48%9K
40.00%28K
45.36%-312K
51.11%-329K
-125.61%-21K
141.67%58K
600.00%20K
-108.19%-571K
-109.70%-673K
1,071.43%82K
Change In working capital
443.53%1.09M
-971.95%-3.08M
-34.91%2.81M
137.06%2.5M
-85.28%223K
-112.34%-317K
142.94%353K
184.76%4.32M
193.28%1.06M
18.36%1.52M
-Change in prepaid assets
80.06%560K
-3.91%246K
50.87%261K
73.72%-385K
-96.48%29K
-48.08%311K
19.63%256K
121.79%173K
-1.60%-1.47M
4.70%825K
-Change in payables and accrued expense
207.39%567K
-2,511.54%-3.14M
-32.24%2.89M
45.30%2.94M
-66.16%355K
-124.86%-528K
114.05%130K
195.98%4.27M
2,061.17%2.02M
68.92%1.05M
-Change in other current assets
247.27%81K
-177.89%-74K
-176.61%-343K
-480.90%-339K
80.44%-44K
-175.00%-55K
196.88%95K
-3,000.00%-124K
4,550.00%89K
-2,350.00%-225K
-Change in other current liabilities
-164.44%-119K
10.16%-115K
----
----
12.69%-117K
66.42%-45K
10.49%-128K
----
----
3.60%-134K
Cash from discontinued investing activities
Operating cash flow
57.21%-5.78M
-4.08%-11.76M
-37.96%-44.59M
-7.03%-9.26M
-50.97%-10.54M
-91.61%-13.5M
-17.18%-11.3M
25.36%-32.32M
46.08%-8.65M
13.40%-6.98M
Investing cash flow
Cash flow from continuing investing activities
202.50%2.01M
32.74%-1.99M
-66.87%9.96M
-88.97%1.94M
355.08%12.95M
-119.47%-1.96M
-139.44%-2.96M
185.40%30.07M
187.82%17.57M
-2,644.86%-5.08M
Net PPE purchase and sale
158.62%17K
--1K
-20.83%-29K
--0
--0
-20.83%-29K
--0
88.68%-24K
--0
--0
Net investment purchase and sale
203.16%1.99M
32.70%-1.99M
-66.80%9.99M
-88.97%1.94M
355.08%12.95M
-119.14%-1.93M
-139.44%-2.96M
185.98%30.09M
187.88%17.57M
-126,850.00%-5.08M
Cash from discontinued investing activities
Investing cash flow
202.50%2.01M
32.74%-1.99M
-66.87%9.96M
-88.97%1.94M
355.08%12.95M
-119.47%-1.96M
-139.44%-2.96M
185.40%30.07M
187.82%17.57M
-2,644.86%-5.08M
Financing cash flow
Cash flow from continuing financing activities
330.62%4.75M
23,594.00%11.85M
5,856.90%6.91M
1,574.51%854K
23,242.86%4.9M
3,706.90%1.1M
233.33%50K
-48.67%116K
-22.73%51K
21K
Net common stock issuance
344.63%4.93M
34,691.18%11.83M
6,712.87%6.88M
1,554.90%844K
23,204.76%4.89M
3,724.14%1.11M
--34K
180.56%101K
41.67%51K
--21K
Proceeds from stock option exercised by employees
--0
12.50%18K
93.33%29K
--0
--13K
--0
6.67%16K
-92.11%15K
--0
--0
Net other financing activities
-3,440.00%-177K
----
----
----
---5K
---5K
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
330.62%4.75M
23,594.00%11.85M
5,856.90%6.91M
1,574.51%854K
23,242.86%4.9M
3,706.90%1.1M
233.33%50K
-48.67%116K
-22.73%51K
--21K
Net cash flow
Beginning cash position
-67.73%7.35M
-74.97%9.25M
-5.48%36.97M
-43.84%15.72M
-79.02%8.4M
-38.47%22.76M
-5.48%36.97M
-66.68%39.11M
-62.73%27.99M
-51.96%40.03M
Current changes in cash
106.86%985K
86.58%-1.91M
-1,195.33%-27.72M
-172.07%-6.47M
160.81%7.32M
-571.10%-14.36M
-568.80%-14.21M
97.27%-2.14M
124.93%8.97M
-46.00%-12.04M
Effect of exchange rate changes
66.67%-1K
-75.00%1K
150.00%2K
-116.67%-1K
114.29%1K
40.00%-3K
100.00%4K
-157.14%-4K
-14.29%6K
-75.00%-7K
End cash Position
-0.83%8.33M
-67.73%7.35M
-74.97%9.25M
-74.97%9.25M
-43.84%15.72M
-79.02%8.4M
-38.47%22.76M
-5.48%36.97M
-5.48%36.97M
-62.73%27.99M
Free cash from
57.30%-5.78M
-4.08%-11.76M
-37.94%-44.62M
-7.03%-9.26M
-50.97%-10.54M
-91.37%-13.53M
-17.18%-11.3M
25.67%-32.35M
46.13%-8.65M
15.30%-6.98M
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
--
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 57.21%-5.78M-4.08%-11.76M-37.96%-44.59M-7.03%-9.26M-50.97%-10.54M-91.61%-13.5M-17.18%-11.3M25.36%-32.32M46.08%-8.65M13.40%-6.98M
Net income from continuing operations 48.67%-7.25M29.51%-9.64M-22.44%-51.21M-19.55%-11.96M-17.08%-11.45M-33.73%-14.13M-19.12%-13.68M36.01%-41.82M58.89%-10M13.73%-9.78M
Operating gains losses --66K--10K--------------------385.71%20K366.67%16K----
Depreciation and amortization -10.53%102K-16.79%109K-11.74%466K10.00%110K-21.28%111K-19.15%114K-10.27%131K-15.11%528K-38.65%100K-9.03%141K
Unrealized gains and losses of investment securities -50.00%1K75.00%-1K---------114.29%-1K--2K---4K----------7K
Remuneration paid in stock -73.08%207K-56.83%809K-29.84%3.65M-52.26%411K-43.11%599K-1.28%769K-25.46%1.87M-59.79%5.21M-62.79%861K-42.40%1.05M
Other non cashItems -84.48%9K40.00%28K45.36%-312K51.11%-329K-125.61%-21K141.67%58K600.00%20K-108.19%-571K-109.70%-673K1,071.43%82K
Change In working capital 443.53%1.09M-971.95%-3.08M-34.91%2.81M137.06%2.5M-85.28%223K-112.34%-317K142.94%353K184.76%4.32M193.28%1.06M18.36%1.52M
-Change in prepaid assets 80.06%560K-3.91%246K50.87%261K73.72%-385K-96.48%29K-48.08%311K19.63%256K121.79%173K-1.60%-1.47M4.70%825K
-Change in payables and accrued expense 207.39%567K-2,511.54%-3.14M-32.24%2.89M45.30%2.94M-66.16%355K-124.86%-528K114.05%130K195.98%4.27M2,061.17%2.02M68.92%1.05M
-Change in other current assets 247.27%81K-177.89%-74K-176.61%-343K-480.90%-339K80.44%-44K-175.00%-55K196.88%95K-3,000.00%-124K4,550.00%89K-2,350.00%-225K
-Change in other current liabilities -164.44%-119K10.16%-115K--------12.69%-117K66.42%-45K10.49%-128K--------3.60%-134K
Cash from discontinued investing activities
Operating cash flow 57.21%-5.78M-4.08%-11.76M-37.96%-44.59M-7.03%-9.26M-50.97%-10.54M-91.61%-13.5M-17.18%-11.3M25.36%-32.32M46.08%-8.65M13.40%-6.98M
Investing cash flow
Cash flow from continuing investing activities 202.50%2.01M32.74%-1.99M-66.87%9.96M-88.97%1.94M355.08%12.95M-119.47%-1.96M-139.44%-2.96M185.40%30.07M187.82%17.57M-2,644.86%-5.08M
Net PPE purchase and sale 158.62%17K--1K-20.83%-29K--0--0-20.83%-29K--088.68%-24K--0--0
Net investment purchase and sale 203.16%1.99M32.70%-1.99M-66.80%9.99M-88.97%1.94M355.08%12.95M-119.14%-1.93M-139.44%-2.96M185.98%30.09M187.88%17.57M-126,850.00%-5.08M
Cash from discontinued investing activities
Investing cash flow 202.50%2.01M32.74%-1.99M-66.87%9.96M-88.97%1.94M355.08%12.95M-119.47%-1.96M-139.44%-2.96M185.40%30.07M187.82%17.57M-2,644.86%-5.08M
Financing cash flow
Cash flow from continuing financing activities 330.62%4.75M23,594.00%11.85M5,856.90%6.91M1,574.51%854K23,242.86%4.9M3,706.90%1.1M233.33%50K-48.67%116K-22.73%51K21K
Net common stock issuance 344.63%4.93M34,691.18%11.83M6,712.87%6.88M1,554.90%844K23,204.76%4.89M3,724.14%1.11M--34K180.56%101K41.67%51K--21K
Proceeds from stock option exercised by employees --012.50%18K93.33%29K--0--13K--06.67%16K-92.11%15K--0--0
Net other financing activities -3,440.00%-177K---------------5K---5K----------------
Cash from discontinued financing activities
Financing cash flow 330.62%4.75M23,594.00%11.85M5,856.90%6.91M1,574.51%854K23,242.86%4.9M3,706.90%1.1M233.33%50K-48.67%116K-22.73%51K--21K
Net cash flow
Beginning cash position -67.73%7.35M-74.97%9.25M-5.48%36.97M-43.84%15.72M-79.02%8.4M-38.47%22.76M-5.48%36.97M-66.68%39.11M-62.73%27.99M-51.96%40.03M
Current changes in cash 106.86%985K86.58%-1.91M-1,195.33%-27.72M-172.07%-6.47M160.81%7.32M-571.10%-14.36M-568.80%-14.21M97.27%-2.14M124.93%8.97M-46.00%-12.04M
Effect of exchange rate changes 66.67%-1K-75.00%1K150.00%2K-116.67%-1K114.29%1K40.00%-3K100.00%4K-157.14%-4K-14.29%6K-75.00%-7K
End cash Position -0.83%8.33M-67.73%7.35M-74.97%9.25M-74.97%9.25M-43.84%15.72M-79.02%8.4M-38.47%22.76M-5.48%36.97M-5.48%36.97M-62.73%27.99M
Free cash from 57.30%-5.78M-4.08%-11.76M-37.94%-44.62M-7.03%-9.26M-50.97%-10.54M-91.37%-13.53M-17.18%-11.3M25.67%-32.35M46.13%-8.65M15.30%-6.98M
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion--------------

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CA
Overall
Symbol
Latest Price
% Chg

No Data